Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRAV.L Regulatory News (RAV)

  • There is currently no data for RAV

EPT Disclosure

12 May 2009 09:28

RNS Number : 0875S
Credit Suisse Securities (Eur) Ltd
12 May 2009
 

FORM 38.5 (b)

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

1. KEY INFORMATION 

Name of exempt principal trader

Credit Suisse Securities (Europe) Limited

Company dealt in

Raven Russia Limited

Class of relevant security to which the dealings being disclosed relate (Note 1)

Ordinary Shares

Date of dealing

11-May-2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

19290

0.004

 

 

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell 

 

 

 

 

Total

19290

0.004

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) 

Class Of Relevant Security : 

Long

Short

(1) Relevant Securities 

 

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase\sell 

 

 

Total

 

 

(c) Rights to subscribe (Note 2) 

Class of relevant security:

Details

 

 

3. DEALINGS (Note 3)

(a) Purchases and sales 

Purchase/sale

Number of securities

Price per unit (Note 4)

Buy

10000

0.275 (GBP)

Buy

4169

0.275 (GBP)

Buy

1163

0.275 (GBP)

Buy

1100

0.275 (GBP)

Buy

1090

0.275 (GBP)

Buy

583

0.2725 (GBP)

Buy

469

0.275 (GBP)

Buy

322

0.275 (GBP)

Buy

200

0.275 (GBP)

Buy

194

0.275 (GBP)

(b) Derivatives transactions (other than options) 

Product name, e.g. CFD

Long/short (Note 5)

Number of securities (Note 6)

Price per unit (Note 4)

 

 

 

 

(c) Options transactions in respect of existing securities 

(i) Writing, selling, purchasing or varying 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 6)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

 

 

 

 

 

(ii) Exercising 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

 

(d) Other dealings (including new securities) (Note 3) 

Nature of transaction (Note 7)

Details

Price per unit (if applicable) (Note 4)

 

 

 

4. OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 38.5(b) attached? (Note 8)  No

Date of disclosure

12-May-2009 07:56:11

Contact name

Collins,Carolyn/ Crawley, Simon

Telephone number

44 20 7888 0241

Name of offeree/offeror with which connected

Raven Russia Limited

Nature of connection (Note 9)

BROKER

Notes  The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMSFWSAESUSEEI
Date   Source Headline
30th Jan 20127:00 amRNSVoting Rights and Capital
3rd Jan 20127:00 amRNSTotal Voting Rights
30th Dec 20117:00 amRNSDirectors' Dealings
30th Dec 20117:00 amRNSIssue of preference shares
1st Dec 20117:00 amRNSVoting Rights and Capital
1st Dec 20117:00 amRNSScrip Dividend Circular
17th Nov 20117:00 amRNSPreference Share Dividend
14th Nov 20117:00 amRNSInterim Management Statement
3rd Nov 20112:36 pmRNSResult of EGM and Tender Offer Alternative
1st Nov 20117:00 amRNSVoting Rights and Capital
10th Oct 201112:47 pmRNSTender Offer Circular & Notice of General Meeting
6th Oct 20112:52 pmRNSTotal Voting Rights
3rd Oct 20117:00 amRNSTotal Voting Rights
30th Sep 20117:00 amRNSDirectors' Dealings
29th Sep 20117:00 amRNSIssue of preference shares
21st Sep 20111:39 pmRNSHolding(s) in Company
19th Sep 20114:22 pmRNSDirector Dealings
19th Sep 20113:35 pmRNSTotal Voting Rights
15th Sep 20113:24 pmRNSHolding(s) in Company
14th Sep 20114:29 pmRNSHolding(s) in Company
9th Sep 20114:33 pmRNSTotal Voting Rights
8th Sep 20114:25 pmRNSProposed Dividend
1st Sep 20117:00 amRNSTotal Voting Rights
1st Sep 20117:00 amRNSScrip Dividend Circular
30th Aug 20117:00 amRNSHalf Yearly Report
18th Aug 20117:00 amRNSPreference Share Dividend
10th Aug 20112:05 pmRNSHolding(s) in Company
2nd Aug 20117:00 amRNSBlocklisting Interim Review
21st Jul 20114:13 pmRNSPublication of Prospectus
18th Jul 20117:00 amRNSTrading Statement
8th Jul 201112:37 pmRNSIntention to List
1st Jul 20117:00 amRNSTotal Voting Rights
30th Jun 20117:00 amRNSDirector/PDMR Shareholding
29th Jun 20117:00 amRNSIssue of preference shares
24th Jun 20115:23 pmRNSDirector/PDMR Shareholding
2nd Jun 201112:50 pmRNSAcquisition update
2nd Jun 20117:00 amRNSScrip Dividend Circular
31st May 20117:00 amRNSIntention to list Preference Shares
19th May 20117:00 amRNSPreference Share Dividend
16th May 20114:11 pmRNSResult of AGM
16th May 20117:00 amRNSInterim Management Statement
3rd May 20117:00 amRNSTotal Voting Rights
21st Apr 20117:00 amRNSNew Letting and Trading Update
13th Apr 20117:00 amRNSDelivery of 2010 Annual Report and Accounts
1st Apr 20117:00 amRNSTotal Voting Rights
31st Mar 20117:00 amRNSDirector/PDMR Shareholding
30th Mar 20117:00 amRNSIssue of Preference Shares
29th Mar 20117:00 amRNSAnnual Information Update
21st Mar 20117:00 amRNSDirector/PDMR Shareholding
14th Mar 20117:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.